Characterization of a Novel, Non-peptidyl Antagonist of the Human Glucagon Receptor-Reference-Cited by-同舟云学术

Characterization of a Novel, Non-peptidyl Antagonist of the Human Glucagon Receptor

Published:1999-03 Issue:13 Volume:274 Page:8694-8697
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Cascieri Margaret A.,Koch Gregory E.,Ber Elzbieta,Sadowski Sharon J.,Louizides Donna,de Laszlo Stephen E.,Hacker Candice,Hagmann William K.,MacCoss Malcolm,Chicchi Gary G.,Vicario Pasquale P.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference15 articles.

1. The roles of insulin and glucagon in the regulation of hepatic glycogen synthesis and turnover in humans.

2. Immunoneutralization of endogenous glucagon with monoclonal glucagon antibody normalizes hyperglycaemia in moderately streptozotocin-diabetic rats

3. Hyperglycemia of Diabetic Rats Decreased by a Glucagon Receptor Antagonist

4. Synthesis of two glucagon antagonists: receptor binding, adenylate cyclase, and effects on blood plasma glucose levels

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GLP-1 metabolite GLP-1(9–36) is a systemic inhibitor of mouse and human pancreatic islet glucagon secretion;Diabetologia;2023-12-21

2. Glucagon and Its Receptors in the Mammalian Heart;International Journal of Molecular Sciences;2023-08-15

3. THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors;British Journal of Pharmacology;2021-09-16

4. Anti-inflammatory and atheroprotective properties of glucagon;Diabetes and Vascular Disease Research;2020-09

5. A combined activation mechanism for the glucagon receptor;Proceedings of the National Academy of Sciences;2020-06-22